Sertraline
Sertraline is one of the most prescribed SSRIs, used for depression, anxiety disorders, OCD, PTSD, and PMDD. It works by blocking the serotonin reuptake transporter (SERT), increasing serotonin availability in the synapse. It typically takes 2–4 weeks to see full therapeutic effects.
Uses & FDA Indications
Sertraline has the broadest range of FDA-approved psychiatric indications of any SSRI — six separate conditions, covering the most prevalent mental health disorders encountered in primary care and psychiatry.
FDA-approved indications include: major depressive disorder (MDD), obsessive-compulsive disorder (OCD) in adults and children aged 6–17, post-traumatic stress disorder (PTSD), social anxiety disorder (social phobia), panic disorder (with or without agoraphobia), and premenstrual dysphoric disorder (PMDD). This breadth, combined with a well-characterized safety profile and low cost as a generic, makes sertraline a frequent first choice for multiple conditions.
Off-label uses include generalized anxiety disorder (GAD), binge eating disorder, body dysmorphic disorder, and premature ejaculation (where SSRIs' sexual side effect of delayed orgasm is therapeutically exploited).
How It Works
Sertraline selectively inhibits the serotonin transporter (SERT) — the protein responsible for reuptaking serotonin from the synaptic cleft back into the presynaptic neuron after it is released. By blocking reuptake, sertraline allows serotonin to remain active in the synapse for longer, increasing serotonergic neurotransmission.
This immediate increase in synaptic serotonin, however, does not explain the therapeutic delay. Antidepressant and anxiolytic effects typically require 4–8 weeks to fully emerge — much longer than the hours it takes serotonin levels to rise. The current understanding is that sustained serotonergic signaling initiates adaptive changes over weeks: downregulation of inhibitory 5-HT1A autoreceptors (which initially dampen serotonin release), neuroplasticity in the hippocampus (including BDNF-mediated neurogenesis), and remodeling of the prefrontal cortex-amygdala circuitry that governs fear and mood regulation. Antidepressant efficacy reflects these adaptive changes, not the acute serotonin increase alone.
Sertraline has a half-life of approximately 26 hours for the parent drug, with an active metabolite (desmethylsertraline) lasting 62–104 hours. This provides relatively smooth plasma levels with once-daily dosing but makes it more prone to discontinuation syndrome than the much longer-acting fluoxetine (half-life ~4–6 days), which essentially self-tapers.
FDA BLACK BOX WARNING — SUICIDALITY IN YOUTH: Antidepressants increase the risk of suicidal thinking and behavior in children, adolescents, and young adults (under 25) with major depressive disorder and other psychiatric disorders. Monitor closely for clinical worsening, agitation, irritability, unusual changes in behavior, and emergence of suicidal ideation — especially during the first 1–2 months of treatment and after dose changes. Sertraline is not approved for use in children under 6 for any indication.
Side Effects
Common
- Nausea — most common early side effect; typically resolves within 1–2 weeks. Take with food, start at lower doses.
- Sexual dysfunction — decreased libido, delayed orgasm, anorgasmia, ejaculatory delay. Affects 30–40% of patients; unlike most side effects, tends not to resolve with time. A common reason for non-adherence. Options include dose reduction, drug holiday on weekends (caution with discontinuation syndrome), or switching to bupropion or mirtazapine.
- Insomnia or sedation — varies by patient; adjust dose timing accordingly
- Increased sweating — often persistent; can be socially distressing
- Diarrhea or loose stools — more common with sertraline than other SSRIs
- Weight gain — modest with short-term use; more pronounced with years of treatment
- Tremor, dry mouth, fatigue
Serious
- Serotonin syndrome — potentially life-threatening excess serotonergic activity. Symptoms: fever, agitation, tremor, diarrhea, hyperreflexia, incoordination, muscle rigidity (severe cases). At therapeutic doses used alone, serotonin syndrome is very rare. The primary risk is combination with other serotonergic drugs (MAOIs, tramadol, triptans, linezolid). Seek emergency care immediately if suspected.
- Bleeding risk — SSRIs deplete platelet serotonin needed for aggregation, raising GI and surgical bleeding risk, especially with NSAIDs or anticoagulants.
- Hyponatremia — SIADH (syndrome of inappropriate ADH secretion), primarily in elderly patients. Presents with confusion, headache, weakness.
- Mania activation — in unrecognized bipolar disorder, SSRIs can precipitate hypomanic or manic episodes.
Drug Interactions
| Drug / Class | Interaction | Clinical Significance |
|---|---|---|
| MAO Inhibitors (phenelzine, tranylcypromine, selegiline, linezolid, methylene blue) | Combined serotonergic activity causes potentially fatal serotonin syndrome. Classic MAOIs and sertraline cannot be used concurrently or within 14 days of each other (washout required in both directions). | CONTRAINDICATED — absolute; linezolid (antibiotic with MAOI activity) and methylene blue are also contraindicated |
| Tramadol | Tramadol inhibits serotonin reuptake and has weak opioid activity. Combined with sertraline, serotonin syndrome risk is meaningfully elevated. Also raises seizure threshold. | High — avoid combination; if pain control required, use an alternative opioid |
| Triptans (sumatriptan, rizatriptan) | Serotonin 5-HT1 agonists used for migraines. Combined serotonergic activity theoretically raises serotonin syndrome risk. FDA issued a warning in 2006, though clinical serotonin syndrome from this combination is rarely confirmed in practice. | Moderate — monitor for symptoms; combination is widely used with appropriate caution |
| Warfarin | Sertraline inhibits CYP2C9, which metabolizes warfarin's more potent S-enantiomer. INR can rise significantly when sertraline is started, stopped, or dose-changed. | Moderate-High — monitor INR within 1–2 weeks of any sertraline change in anticoagulated patients |
| NSAIDs (ibuprofen, naproxen) | SSRIs deplete platelet serotonin (which normally promotes aggregation) while NSAIDs inhibit COX-mediated thromboxane synthesis. Combined effect on hemostasis raises GI bleeding risk approximately 3-fold versus either drug alone. | Moderate — use lowest NSAID dose for shortest duration; consider PPI co-prescription; prefer acetaminophen for analgesia |
| Pimozide | Sertraline substantially increases pimozide plasma levels via CYP2D6 inhibition, raising QT prolongation and arrhythmia risk. | CONTRAINDICATED — absolute; do not combine |
| Lithium | Pharmacodynamic synergy raises serotonin syndrome risk. Lithium may also enhance sertraline efficacy (used therapeutically as augmentation in treatment-resistant depression). | Moderate — monitor for serotonin syndrome symptoms if combined |
Warnings & Contraindications
Contraindications
- Concomitant use with MAO inhibitors, linezolid, or IV methylene blue
- Concomitant use with pimozide
- Hypersensitivity to sertraline
Discontinuation Syndrome
Because sertraline's half-life (26 hours) is shorter than fluoxetine's, abrupt discontinuation frequently causes discontinuation syndrome within 1–3 days: "brain zaps" (brief electrical shock sensations), flu-like symptoms (myalgias, fatigue), dizziness, irritability, insomnia, and vivid dreams. These are not signs of addiction but of neurological readjustment. Always taper sertraline over several weeks to months, with slower tapers after longer treatment durations.
Check for serotonin syndrome risk or other interactions with sertraline.
Check Drug Interactions →Frequently Asked Questions
Will sertraline change my personality?
No — sertraline does not change who you are. It treats symptoms of depression, anxiety, PTSD, OCD, and related disorders by restoring neurochemical balance. Patients and their families sometimes notice the person is "more themselves" — less withdrawn, less reactive, more engaged — as symptoms lift. Occasional reports of emotional blunting (feeling less intensity of emotions, both positive and negative) do occur; if this is bothersome, discuss dose adjustment or medication change with your provider. The goal of treatment is symptom relief without dulling your personality.
Can I drink alcohol while taking sertraline?
It is best to avoid alcohol entirely, particularly during the first few weeks when you are still establishing how sertraline affects you. Alcohol is a CNS depressant that worsens depression and anxiety, directly counteracting sertraline's therapeutic purpose. It also increases the CNS side effects (sedation, cognitive impairment) of sertraline. After you are stable on sertraline, some patients tolerate light occasional alcohol, but there is no safe threshold — even moderate drinking can worsen mental health outcomes in people managing depression or anxiety.
How long do I need to take sertraline?
For a first episode of major depression, most guidelines recommend continuing sertraline for at least 6–12 months after achieving remission — stopping sooner increases relapse risk significantly. For recurrent depression (two or more episodes) or chronic anxiety disorders, longer-term treatment (years or indefinitely) is often appropriate and evidence-supported. The decision to discontinue should be made jointly with your provider based on symptom stability, life circumstances, and prior history — not a fixed timeline. Discontinuation, when appropriate, should always be a gradual taper.
What happens if sertraline doesn't work after 8 weeks?
Approximately 50–60% of patients respond to the first antidepressant tried. If sertraline is not providing adequate relief at 8–12 weeks at an adequate dose (typically 100–200 mg for depression), options include: increasing the dose to the maximum (200 mg), augmenting with another agent (buspirone, lithium, atypical antipsychotic), switching to a different antidepressant class (SNRI, bupropion, mirtazapine), or adding psychotherapy. Non-response to one SSRI does not mean others or other classes will fail — it often takes systematic adjustment to find the right treatment for each individual.